227 related articles for article (PubMed ID: 37975253)
21. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
[TBL] [Abstract][Full Text] [Related]
22. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
23. REDD1 deletion attenuates cancer cachexia in mice.
Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
Wang Y; Sun X; Yang Q; Guo C
Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
[TBL] [Abstract][Full Text] [Related]
25. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
[TBL] [Abstract][Full Text] [Related]
27. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H
Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241
[TBL] [Abstract][Full Text] [Related]
29. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
[TBL] [Abstract][Full Text] [Related]
30. Carnosol analogue WK-63 alleviated cancer cachexia by inhibiting NF-κB and activating AKT pathways in muscle while inhibiting NF-κB and AMPK pathways in adipocyte.
Pan X; Zhang G; Wei K; Gu X; Dan J; Zhao Y; Liu X; Cheng C; Zhang X
Toxicol Appl Pharmacol; 2023 Nov; 479():116729. PubMed ID: 37863360
[TBL] [Abstract][Full Text] [Related]
31. Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.
Ojima C; Noguchi Y; Miyamoto T; Saito Y; Orihashi H; Yoshimatsu Y; Watabe T; Takayama K; Hayashi Y; Itoh F
Cancer Sci; 2020 Aug; 111(8):2954-2964. PubMed ID: 32519375
[TBL] [Abstract][Full Text] [Related]
32. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
33. Opposing effects of 25-hydroxy- and 1α,25-dihydroxy-vitamin D
Sustova H; De Feudis M; Reano S; Alves Teixeira M; Valle I; Zaggia I; Agosti E; Prodam F; Filigheddu N
Acta Physiol (Oxf); 2019 Jul; 226(3):e13269. PubMed ID: 30834670
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
35. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
Proteomics; 2024 Jun; 24(11):e2300020. PubMed ID: 37882347
[TBL] [Abstract][Full Text] [Related]
36. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
Zhang G; Jin B; Li YP
EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
[TBL] [Abstract][Full Text] [Related]
38. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
39. Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling.
Morinaga M; Sako N; Isobe M; Lee-Hotta S; Sugiura H; Kametaka S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803685
[TBL] [Abstract][Full Text] [Related]
40. A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia.
Gonzalez A; Cheung WW; Perens EA; Oliveira EA; Gertler A; Mak RH
Cells; 2021 Jul; 10(8):. PubMed ID: 34440723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
